Pulmonary arterial hypertension associated with interferon therapy: a population-based study

ConclusionAlthough our analysis showed that the development of PAH is a rare event with interferon therapy, the risk of developing the disease is several fold higher than that for the general population.

Source: Multidisciplinary Respiratory Medicine - January 16, 2017 Category: Respiratory Medicine Source Type: research